Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Market EXTON, PA, May 01, 2024 (GLOBE NEWSWIRE) -- In the landscape of healthcare innovation, retinal disorders, including both inherited and degenerative diseases, have become a leading focus area for...

Macular Degeneration Treatment Market to Expand USD 21.1 Bn by 2031, Registering at a CAGR of 8.8% | Exclusive Report by Transparency Market Research Wilmington, Delaware, United States, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global macular degeneration treatment market is projected to exceed US$ 21.1 Bn by...

Ophthalmic Drugs Market to Develop at CAGR of 6.83% during Forecast Period: TMR Study Wilmington, Delaware, United States, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - In 2021, the value of the ophthalmic drugs market stood at US$ 26.46 Bn. Analysis of...

Amarantus Announces Issuance of Chinese Patent Covering the Use of MANF and CDNF in Retinal Disorders for Subsidiary MANF Therapeutics Patent covers use of MANF in Glaucoma, Wolfram Syndrome and Retinitis Pigmentosa New York, NY, Nov. 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Amarantus Bioscience Holdings, Inc. (OTC...